ABC | Volume 113, Nº2, August 2019

Review Article Lamounier Júnior et al. Genetic and dilated cardiomyopathy Arq Bras Cardiol. 2019; 113(2):274-281 This is an open-access article distributed under the terms of the Creative Commons Attribution License 38. Priori SG, Blomström-Lundqvist C, Mazzanti A, BlomN, BorggrefeM, Camm J, et al. 2015 ESCGuidelines for themanagement of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for theManagementofPatientswithVentricularArrhythmiasandthePrevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric andCongenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-867. 39. Charron P, Arbustini E, Bonne G. What Should the Cardiologist know about Lamin Disease? Arrhythm Electrophysiol Rev. 2012;1(1):22-8. 40. Captur G, Arbustini E, Syrris P, Radenkovic D, O’Brien B, Mckenna WJ, et al. Laminmutation location predicts cardiac phenotype severity: combined analysis of the published literature. Open Heart. 2018;5(2):e000915. 41. Kayvanpour E, Sedaghat-Hamedani F, Amr A, Lai A, Haas J, Holzer DB, et al. Genotype-phenotypeassociations indilatedcardiomyopathy:meta-analysis on more than 8000 individuals. Clin Res Cardiol. 2017;106(2):127-39. 42. Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, et al. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures. JACC Clin Electrophysiol. 2018;4(4):504-14. 43. Norton N, Li D, Rieder MJ, Siegfried JD, Rampersaud E, Züchner S et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J HumGenet. 2011;88(3):273-82. 44. Reinstein E, Gutierrez-Fernandez A, Tzur S, Bormans C, Marcu S, Tayeb- Fligelman E et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C. Eur J HumGenet. 2016;24(12):1792-6. 45. Chami N, Tadros R, Lemarbre F, Lo KS, BeaudoinM, Robb L, et al. Non sense mutations in BAG3 are associatedwith early-onset dilated cardiomyopathy in French Canadians. Can J Cardiol. 2014;30(12):1655-61. 46. Toro R, Pérez-Serra A, CampuzanoO, Moncayo-Arlandi J, Allegue C, Iglesias A, et al. Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene. PLoSOne. 2016;11(7):e0158730. 47. RafiqMA, Chaudhry A, CareM, Spears DA, Morel CF, Hamilton RM.Whole exome sequencing identified 1 base pair novel deletion in BCL2-associated athanogene 3 (BAG3) gene associated with severe dilated cardiomyopathy (DCM) requiring heart transplant in multiple family members. Am J Med Genet A. 2017;173(3):699-705. 48. Hermida-PrietoM,MonserratL,Castro-BeirasA,LaredoR,SolerR,PeteiroJet al.Familialdilatedcardiomyopathyandisolatedleftventricularnoncompaction associatedwith lamin A/C genemutations. Am J Cardiol. 2004;94(1):50-4. 49. Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J. 2017;38(46):3449-60. 50. López-Ayala JM, Gómez-Milanés I, Sánchez Muñoz JJ, Ruiz-Espejo F, Ortíz M, González-Carrillo J, et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. Europace. 2014;16(12):1838-46. 51. Groeneweg JA, van der Zwaag PA, Jongbloed JD, Cox MG, Vreeker A, de Boer RA, et al. Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or non desmosomal genotype? Heart Rhythm. 2013;10(4):548-59. 52. Garcia-Pavia P, Syrris P, Salas C, Evans A, Mirelis JG, Cobo-Marcos M, et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinic pathological study. Heart. 2011;97(21):1744-52. 53. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005;45(7):969-81. 54. Girolami F, Frisso G, Benelli M, Crotti L, Iascone M, Mango R, et al. Contemporarygenetictesting in inheritedcardiacdisease:tools,ethical issues, and clinical applications. T cardiovasc Med(Hagerstown). 2018;19(1):1-11 55. Van Berlo JH, de Voogt WG, van der Kooi AJ, van Tintelen JP, BonneG, Yaou RB,et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations :portend a high risk of sudden death¿ J Mol Med (Berl). 2005;83(1):79-83. 281